Question 1

Who are the top researchers at Dr Falk Pharma (Germany)?

Accepted Answer

Ranked on the quality score, Ralph Müeller, Roland Greinwald and Karin Dilger lead among researchers whose main affiliation is Dr Falk Pharma (Germany).

Question 2

What are the most cited papers from Dr Falk Pharma (Germany)?

Accepted Answer

The most cited paper from Dr Falk Pharma (Germany) is "Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis" (Michael Peter Manns, Marek Woynarowski, Wolfgang Kreisel et al., 2010), with 447 citations. Next come "Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial" (306) and "norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis" (295).

Question 3

Which research topics does Dr Falk Pharma (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Eosinophilic Esophagitis, Inflammatory Bowel Disease, Celiac Disease Research and Management and Gastric Cancer Management and Outcomes.

Question 4

Which keywords describe research at Dr Falk Pharma (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Management, Inflammatory Bowel Disease, Pathogenesis, Treatment, Guidelines and Children.

Question 5

Which fields of science does Dr Falk Pharma (Germany) work in?

Accepted Answer

In all years, 72% of research at Dr Falk Pharma (Germany) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (69%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (3%). It does 2.6× the world's share of Health Sciences.

Question 6

Is Dr Falk Pharma (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 178% higher than in 2018-2021.